Development and Validation of Novel MRI Methods for the Detection of Prostate Cancer Aggressiveness
NCT02545881 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2016-10-19
Summary
The purpose of this study is to develop, validate, and evaluate the correlation of novel magnetic resonance imaging (MRI) methods with prostate cancer aggressiveness and histological data obtained during prostatectomy.
Conditions
Interventions
- OTHER
-
Magnetic Resonance Imaging (MRI)
MRI of the prostate prior to prostatectomy
Sponsors & Collaborators
-
Turku University Hospital
lead OTHER_GOV
Eligibility
- Min Age
- 30 Years
- Max Age
- 85 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-07-31
- Primary Completion
- 2018-12-31
Countries
- Finland
Study Locations
More Related Trials
-
Assessment of Prostate MRI Before Prostate Biopsies
NCT02485379 ·Status: COMPLETED ·Phase: NA
-
MRI/MRSI in Risk Assessment of Prostate Cancer Patients
NCT00582543 ·Status: COMPLETED ·Phase: NA
-
Improving Prostate Cancer Detection Using MRI-Targeted TRUS-Guided Biopsy
NCT02488096 ·Status: COMPLETED ·Phase: NA
-
MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness
NCT01464216 ·Status: ACTIVE_NOT_RECRUITING
-
Magnetic Resonance Imaging to Locate and Characterize Prostate Cancer
NCT00082147 ·Status: COMPLETED ·Phase: NA
-
A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate Cancer
NCT01858688 ·Status: COMPLETED ·Phase: NA
-
Characterize Tumor Hypoxia by Magnetic Resonance Imaging
NCT03987568 ·Status: WITHDRAWN ·Phase: NA
-
Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Diagnosing the Extent of Disease in Patients With Prostate Cancer
NCT00032058 ·Status: COMPLETED ·Phase: NA
-
Contrast Enhanced MRI of the Prostate
NCT02245282 ·Status: COMPLETED
-
Molecular PET/MR Imaging in Vivo Validation of Biomarker for Human Prostate Cancer
NCT03451812 ·Status: UNKNOWN
-
Clinico-pathologic Correlative Study of 3T Magnetic Resonance Spectroscopy in the Localization of Prostate Cancer
NCT00310479 ·Status: COMPLETED ·Phase: NA
-
Improved Prostate Cancer Diagnosis - Combination of Magnetic Resonance Imaging and Biomarkers
NCT01864135 ·Status: COMPLETED ·Phase: NA
-
Magnetic Resonance Imaging in Detecting Cancer Progression in Patients With Early Stage Prostate Cancer Undergoing Active Surveillance
NCT00796874 ·Status: WITHDRAWN ·Phase: NA
-
Evaluation of Diagnostic Value of 3-T Magnetic Resonance Imaging (MRI) in Suspected Prostate Cancer
NCT01357512 ·Status: COMPLETED ·Phase: NA
-
Multiparametric MRI in Men With Prostate Cancer Undergoing Active Surveillance
NCT02526797 ·Status: ENROLLING_BY_INVITATION
-
MRI in Active Surveillance of Prostate Cancer
NCT02326246 ·Status: COMPLETED ·Phase: NA
-
Novel MRI Assessment of Prostate Cancer VALIDATE-PRO
NCT05017181 ·Status: UNKNOWN
-
bpMRI and Risk Based Shared Clinical Decision Making in Prostate Cancer Diagnosis
NCT04287088 ·Status: RECRUITING ·Phase: NA
-
Prostate Biopsies With Target Lesion on MRI
NCT04692207 ·Status: COMPLETED
-
uPAR-PET/MRI in Patients With Prostate Cancer for Evaluation of Tumor Aggressiveness
NCT03307460 ·Status: UNKNOWN ·Phase: PHASE2
-
Multiparametric MRI in Men With Prostate Cancer Enrolled in Active Surveillance
NCT03648359 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Biparametric MRI for Detection of Significant Prostate Cancer
NCT02584179 ·Status: COMPLETED ·Phase: NA
-
MRI in Clinical Staging and Estimation of Treatment Response in Bladder Cancer
NCT02662166 ·Status: COMPLETED ·Phase: NA
-
Magnetic Resonance Imaging to Evaluate Prostate Cancer
NCT00182624 ·Status: COMPLETED
-
Quantitative mpMRI to Predict Metastatic Potential of Prostate Cancer
NCT05252806 ·Status: UNKNOWN